Capstone Investment Advisors, LLC Biomarin Pharmaceutical Inc Put Options Transaction History

Capstone Investment Advisors, LLC

5 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q2 2021 Aug 16, 2021	SELL	$75.51 - $84.79 $3.22 Million - $3.61 Million	-42,600 Reduced 63.02%	25,000 $2.09 Million
Q1 2021 May 17, 2021	SELL	$74.73 - $90.69 $216,717 - $263,001	-2,900 Reduced 4.11%	67,600 $5.1 Million
Q4 2020 Feb 16, 2021	BUY	$72.61 - $90.2 $1.16 Million - $1.44 Million	16,000 Added 29.36%	70,500 $6.18 Million
Q3 2020 Nov 16, 2020	BUY	$71.87 - $131.03 $2.52 Million - $4.59 Million	35,000 Added 179.49%	54,500 $4.15 Million
Q2 2020 Aug 14, 2020	BUY	$79.55 - $124.22 $1.55 Million - $2.42 Million	19,500 New	19,500 $2.41 Million

632

185M

1.63M

1.2M

Ticker BMRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,824,000
Market Cap $13.1B
Description
BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...

Get notified when there are updates to the investment portfolio of Capstone Investment Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Capstone Investment Advisors, LLC with notifications on news.